IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
216 hedge funds and large institutions have $922M invested in Immunogen Inc in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 64 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $1.41B → $922M (-$484M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
216
Holding in Top 10
2
Calls
$7.09M
Puts
$1.7M
Top Buyers
| 1 | +$26.8M | |
| 2 | +$16.5M | |
| 3 | +$7.47M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.14M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.19M |
Top Sellers
| 1 | -$28.7M | |
| 2 | -$28.7M | |
| 3 | -$15.4M | |
| 4 |
Millennium Management
New York
|
-$7.37M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$5.56M |